Patients with a BRCA1 deficiency develop BLBCs that are enriched with tumor-initiating cells (TICs) and exhibit epithelial-mesenchymal transition (EMT) characteristics [15, 16]. The gene discussed is BRCA1; the disease is neoplasm.